NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 26 of 26 results found.

Activity Company Description Location
Company APIE Therapeutics Inc. Activity: Research and Development Research and Development Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. Location Cary
Company Agile Sciences Inc. Activity: Research and Development Research and Development Company Description Agile Sciences is developing small molecules that inhibit bacterial resistance through a novel mode of action that enhances antibiotic activity. Location Raleigh
Company Altavant Sciences Inc. Activity: Research and Development Research and Development Company Description Altavant is a clinical stage biopharmaceutical company developing therapies for rare respiratory diseases. Altavant's therapeutic focus is in pulmonary arterial hypertension (PAH) and bronchiolitis obliterans syndrome (BOS). Location Cary
Company AstraZeneca (Durham) Activity: Research and Development Research and Development Company Description AstraZeneca's site in Durham develops combination therapies and formulations of inhaled drugs for chronic respiratory diseases such as asthma and COPD. Location Durham
Company Aurobindo Pharma USA Inc. Activity: Research and Development Research and Development Company Description Aurobindo Pharma is a generic drug manufacturer. Aurobindo develops inhalation and dermatological products from the company's U.S. research and development headquarters in North Carolina. Location Durham
Company BD Technologies and Innovation Activity: Research and Development Research and Development Company Description BD Technologies and Innovation develops technologies for parenteral drug delivery, advanced diagnostics, smart medical devices and genomic research and supports external innovation. The RTP site is BD's corporate technology R&D and innovation center. Location Research Triangle Park
Company BioMarck Pharmaceuticals Ltd. Activity: Research and Development Research and Development Company Description BioMarck develops drugs to treat pulmonary diseases and disorders, such as chronic obstructive pulmonary disease, ARDS, cystic fibrosis and lung cancer. Location Durham
Company BioMedInnovations LLC Activity: Research and Development Research and Development Company Description BioMedInnovations (BMI) makes precision air and fluid flow devices, including products for lung ventilators and ex-vivo organ and tissue perfusion. Location Denver
Company BreStem Therapeutics Inc. Activity: Research and Development Research and Development Company Description BreStem Therapeutics is developing a stem cell therapy to treat pulmonary fibrosis. Location Raleigh
Company Chiesi USA Inc. Activity: Research and Development Research and Development Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. Location Cary
Company Columbia Life Systems Inc. Activity: Research and Development Research and Development Company Description Columbia Life Systems is developing a computer-controlled oxygen blender for therapeutic research. Location Chapel Hill
Company Concentrx Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Concentrx develops inhaled prescription products for asthma and COPD, including a unit dose disposable dry powder inhaler. Location Durham
Company Eldec Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. Location Chapel Hill
Company GSK Activity: Research and Development Research and Development Company Description GSK develops and manufactures vaccines, medicines and consumer healthcare products, with a focus on science related to the immune system, use of genetics and advanced technologies. Location Research Triangle Park
Company Inhalon Biopharma Inc. Activity: Research and Development Research and Development Company Description Inhalon Biopharma is developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract. Location Carrboro
Company Irex Pharma LLC Activity: Research and Development Research and Development Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. Location Chapel Hill
Company Oriel Therapeutics Inc., a Sandoz company (Durham) Activity: Research and Development Research and Development Company Description Oriel operates as Sandoz' product development center, which develops respiratory products as generic alternatives to patented drugs for asthma and COPD. It also develops and commercializes pre-metered unit and multi-dose dry powder delivery systems. Location Durham
Company Parion Sciences Inc. Activity: Research and Development Research and Development Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory and ophthalmology diseases. Location Durham
Company Path BioAnalytics Inc. Activity: Research and Development Research and Development Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. Location Durham
Company Renovion Inc. Activity: Research and Development Research and Development Company Description Renovion is developing therapies for chronic inflammatory lung diseases including lung transplant, cystic fibrosis (CF), bronchiectasis and COPD. Location Chapel Hill
Company ReViral Activity: Research and Development Research and Development Company Description ReViral develops antiviral compounds that target respiratory syncytial virus (RSV). Location Durham
Company Sunday Therapeutics Inc. Activity: Research and Development Research and Development Company Description Sunday Therapeutics is developing a humanized monoclonal antibody to prevent chronic lung disease. Location Durham
Company United Therapeutics Corp. Activity: Research and Development Research and Development Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. Location Research Triangle Park
Company Vast Therapeutics Activity: Research and Development Research and Development Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. Location Durham
Company Verona Pharma Inc. Activity: Research and Development Research and Development Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). Location Raleigh
Company X-in8 Biologicals Corp. Activity: Research and Development Research and Development Company Description X-in8 Biologicals develops technologies to prevent and treat ischemia reperfusion injury in the context of organ transplant, myocardial infarction and stroke. Location Chapel Hill